Literature DB >> 8340407

HIV-1 core promoter lacks a simple initiator element but contains a bipartite activator at the transcription start site.

B Zenzie-Gregory1, P Sheridan, K A Jones, S T Smale.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) core promoter region, extending approximately from nucleotides -40 to +80 relative to the transcription start site, contains a complex array of putative regulatory elements, including a TATA box, an initiator element, an element between the TATA box and start site, binding sites for LBP/UBP, the TAR element, and others. However, because of this elaborate architecture, the precise boundaries and functional roles for the individual regulatory elements have not been defined. To facilitate a detailed analysis of the HIV-1 core promoter, we employed in vitro transcription assays to identify the simplest control elements that activate RNA synthesis in the context of a synthetic, heterologous promoter. Because mutations at the start site previously were shown to diminish transcription, we anticipated finding an initiator as a basic regulator. However, we have demonstrated that the HIV-1 core promoter lacks an initiator that is functionally analogous to those found in the terminal transferase and adenovirus major late promoters. In its place, we identified two elements between -6 and +30, both of which appear to be necessary for significant transcriptional activation. Unlike a strong initiator, the activity of these elements was dependent on the presence of a TATA box and on their position relative to TATA. We have called the region containing these two elements the HIV-1 SSR to distinguish it from the simple transcriptional initiator elements found in other genes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8340407

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Transcriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box-dependent manner.

Authors:  C Suñé; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

2.  The Rous sarcoma virus long terminal repeat promoter is regulated by TFII-I.

Authors:  C M Mobley; L Sealy
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

3.  Normal transcription of the C1 inhibitor gene is dependent upon a polypurine-polypyrimidine region within the promoter.

Authors:  Kamyar Zahedi; Anne E Prada; Aideen Mulligan; Jorge A Prada; Alvin E Davis
Journal:  Inflammation       Date:  2002-08       Impact factor: 4.092

Review 4.  Transcriptional and posttranscriptional regulation of HIV-1 gene expression.

Authors:  Jonathan Karn; C Martin Stoltzfus
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

Review 5.  Regulation of HIV-1 transcription.

Authors:  K A Roebuck; M Saifuddin
Journal:  Gene Expr       Date:  1999

6.  NF-kappa B homodimer binding within the HIV-1 initiator region and interactions with TFII-I.

Authors:  M A Montano; K Kripke; C D Norina; P Achacoso; L A Herzenberg; A L Roy; G P Nolan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

7.  DNA sequence requirements for transcriptional initiator activity in mammalian cells.

Authors:  R Javahery; A Khachi; K Lo; B Zenzie-Gregory; S T Smale
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

8.  cis-acting sequences located downstream of the human immunodeficiency virus type 1 promoter affect its chromatin structure and transcriptional activity.

Authors:  A el Kharroubi; M A Martin
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

9.  The RNA element encoded by the trans-activation-responsive region of human immunodeficiency virus type 1 is functional when displaced downstream of the start of transcription.

Authors:  M J Churcher; A D Lowe; M J Gait; J Karn
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

10.  Role of flanking E box motifs in human immunodeficiency virus type 1 TATA element function.

Authors:  S H Ou; L F Garcia-Martínez; E J Paulssen; R B Gaynor
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.